These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29370485)

  • 41. Untreated duration predicted the severity of depression at the two-year follow-up point.
    Hung CI; Liu CY; Yang CH
    PLoS One; 2017; 12(9):e0185119. PubMed ID: 28934289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorder.
    Gao K; Wu R; Wang Z; Ren M; Kemp DE; Chan PK; Conroy CM; Serrano MB; Ganocy SJ; Calabrese JR
    J Psychiatr Res; 2015 Jan; 60():117-24. PubMed ID: 25438963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
    Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
    J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The validity of dysthymia to predict clinical depressive symptoms as measured by the Hamilton Depression Scale at the 5-year follow-up of patients with first episode depression.
    Bech P; Kessing LV; Bukh JD
    Nord J Psychiatry; 2016 Nov; 70(8):563-6. PubMed ID: 27181030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent depressive disorder has long-term negative impacts on depression, anxiety, and somatic symptoms at 10-year follow-up among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH
    J Affect Disord; 2019 Jan; 243():255-261. PubMed ID: 30248637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).
    Spijker J; Bijl RV; de Graaf R; Nolen WA
    Acta Psychiatr Scand; 2001 Jul; 104(1):19-24. PubMed ID: 11437745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder.
    Gaspersz R; Lamers F; Kent JM; Beekman AT; Smit JH; van Hemert AM; Schoevers RA; Penninx BW
    J Clin Psychiatry; 2017 Feb; 78(2):207-213. PubMed ID: 27035515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder.
    Gottschalk MG; Cooper JD; Chan MK; Bot M; Penninx BW; Bahn S
    Brain Behav Immun; 2015 Aug; 48():123-31. PubMed ID: 25929723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life in major depressive disorder: the role of pain and pain catastrophizing cognition.
    Chung KF; Tso KC; Yeung WF; Li WH
    Compr Psychiatry; 2012 May; 53(4):387-95. PubMed ID: 21684536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice?
    Zimmerman M; Walsh E; Friedman M; Boerescu DA; Attiullah N
    J Affect Disord; 2018 Jan; 225():449-452. PubMed ID: 28858659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial.
    Husain MI; Chaudhry IB; Husain N; Khoso AB; Rahman RR; Hamirani MM; Hodsoll J; Qurashi I; Deakin JF; Young AH
    J Psychopharmacol; 2017 Sep; 31(9):1166-1175. PubMed ID: 28857658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The remission from depression questionnaire as an outcome measure in the treatment of depression.
    Zimmerman M; Martinez JH; Attiullah N; Friedman M; Toba C; Boerescu DA
    Depress Anxiety; 2014 Jun; 31(6):533-8. PubMed ID: 24115164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression.
    Rhebergen D; Beekman AT; Graaf Rd; Nolen WA; Spijker J; Hoogendijk WJ; Penninx BW
    J Affect Disord; 2009 Jun; 115(3):450-9. PubMed ID: 19042028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations of Leisure-Time and Occupational Physical Activity and Cardiorespiratory Fitness With Incident and Recurrent Major Depressive Disorder, Depressive Symptoms, and Incident Anxiety in a General Population.
    Baumeister SE; Leitzmann MF; Bahls M; Dörr M; Schmid D; Schomerus G; Appel K; Markus MR; Völzke H; Gläser S; Grabe HJ
    J Clin Psychiatry; 2017 Jan; 78(1):e41-e47. PubMed ID: 28129498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depressive and anxiety disorders: Associated with losing or gaining weight over 2 years?
    de Wit LM; van Straten A; Lamers F; Cuijpers P; Penninx BW
    Psychiatry Res; 2015 Jun; 227(2-3):230-7. PubMed ID: 25895491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
    Cristancho P; Cristancho MA; Baltuch GH; Thase ME; O'Reardon JP
    J Clin Psychiatry; 2011 Oct; 72(10):1376-82. PubMed ID: 21295002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
    Ferentinos P; Kontaxakis VP; Havaki-Kontaxaki BJ; Dikeos D; Papadimitriou GN; Lykouras L
    Psychiatriki; 2011; 22(4):320-9. PubMed ID: 22271845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.